Stock SWAV SHOCKWAVE MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-03 pm EDT 		5-day change 1st Jan Change
330.4 USD +0.12% Intraday chart for Shockwave Medical, Inc. +0.12% +73.37%
Apr. 11 Health Care Slips on Risk Bias -- Health Care Roundup DJ
Apr. 09 CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368 MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 68.36 times its estimated earnings per share for the ongoing year.
  • Based on current prices, the company has particularly high valuation levels.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.37% 12.39B
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-17.09% 8.08B
C+
MASIMO CORPORATION Stock Masimo Corporation
+16.88% 7.25B
C-
GETINGE AB Stock Getinge AB
+3.57% 5.86B
B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+11.77% 5.35B
D+
APT MEDICAL INC. Stock APT Medical Inc.
+29.65% 4.63B -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-17.74% 4.19B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-35.26% 2.44B
C
SKAN GROUP AG Stock SKAN Group AG
+3.09% 2.07B -
SHENZHEN YHLO BIOTECH CO., LTD. Stock Shenzhen YHLO Biotech Co., Ltd.
+4.85% 1.88B -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SWAV Stock
  4. Ratings Shockwave Medical, Inc.